Rhythm

Caelum Biosciences Announces Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis

NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) — Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ:FBIO) Company developing treatments for rare and life-threatening diseases, today announced a complete analysis of cardiac data from Columbia University’s (“Columbia”) Phase 1b trial that supports CAEL-101’s (mAb 11-1F4) potential to improve myocardial function as […]

Stereotaxis and Johnson & Johnson’s Biosense Webster Extend Development Alliance and Supply Agreement

ST. LOUIS, June 25, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today that it has entered into an amendment to the long-term Development Alliance and Supply Agreement with Johnson & Johnson’s Biosense Webster, Inc. The amendment […]

New Study Demonstrates Accuracy of Fully-Automated Ejection Fraction Calculation Using Bay Labs’ EchoMD AutoEF Software

Study Results Presented at American Society of Echocardiography Annual Scientific Sessions NASHVILLE, Tenn. – June 25, 2018 – Bay Labs, a medical technology company at the forefront of applying artificial intelligence (AI) to cardiovascular imaging, today announced its EchoMD AutoEF deep learning software has less variability in evaluating left ventricular […]

BioTrace Medical Announces Key Events Featuring Tempo® Lead at TVT 2018

MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the Transcatheter Valve Therapies (TVT) structural heart disease summit, which will take place June 20-22 at the Sheraton Grand Chicago. The company’s Tempo® Temporary Pacing Lead will be featured in a […]

Caelum Biosciences Announces Presentation of Complete Cardiac Data Analysis from Phase 1b Trial of CAEL-101 in AL Amyloidosis at American Society of Echocardiography 29th Annual Scientific Sessions

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) — Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ:FBIO) Company developing treatments for rare and life-threatening diseases, today announced that Columbia University (“Columbia”) will present a complete analysis of cardiac data from the Phase 1b trial of CAEL-101 (mAb 11-1F4) for the […]

Milestone Pharmaceuticals Announces Launch of OutsmartPSVT.com Supporting Patients with PSVT, a Common and Underdiagnosed Heart Disorder

CHARLOTTE, N.C., June 18, 2018 /PRNewswire/ — Milestone Pharmaceuticals USA Inc., a clinical stage cardiovascular company, today announced the launch of OutsmartPSVT.com, a new educational online resource for patients living with a recurring and sporadic heart arrhythmia called paroxysmal supraventricular tachycardia (PSVT). The website is designed to help fill a long-standing information gap in the PSVT […]

Leviticus Cardio Announces Successful Animal Trial Demonstrating Wireless Power to Jarvik 2000

PETAH TIKVA, Israel, June 18, 2018 /PRNewswire/ — Leviticus Cardio, inventor of wireless technology for certain medical devices, announces the successful animal implantation of the world’s first Hybrid Wireless Fully Implanted Ventricular Assisted System or “Hybrid FILVAS.” The new cardio device, designed for human patients with chronic heart conditions requiring an implanted heart pump, can be […]

Novoheart Wins Coveted 2018 MedTech Breakthrough Award

VANCOUVER, British Columbia, June 13, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that its MyHeart™ platform has been selected as 2018’s “Best New Technology Solution – Drug Development” by MedTech Breakthrough, an independent organization that recognizes the top companies, technologies […]

DIAGNOS Announces the Availability of its New CARA High Blood Pressure Risk Assessment Based on its FLAIRE Artificial Intelligence Platform

BROSSARD, Quebec, June 12, 2018 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the availability of its first cardio application called HTA.  This innovative […]